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INTRODUCTION
Metastasis is the ability of cancer cells to spread from its origin to distant locations within the body and to continue its growth (Valastyan and Weinberg, 2011) . The high mortality rates associated with cancer are caused by the metastatic spread of tumor cells away from the site of their origin (Park et al., 2013a) . In fact, metastases are the cause of 90% of cancer deaths (Steeg, 2006) . Therefore, several researchers are trying to develop new anti-metastatic compounds. Recently, novel approaches have been proposed to characterize the properties of metastatic cancer cells, such as cell elasticity or mechanical properties (Beil et al., 2003; Suresh, 2007) . The clinical importance of viscoelasticity or cell stiffness was reported by Cross et al. (2007) . In particular, the importance of cell elasticity or viscoelasticity in several metastatic cancer cell lines has also been reported (Beil et al., 2003; Rolli et al., 2010) . For example, sphingosylphosphorylcholine (SPC)-induced keratin phosphorylation and reorganization of human epithelial pancreatic cancer cells combined with the resulting changes in viscoelasticity of the cells have been suggested as a possible pathway that facilitates the migration and increased metastatic competence of pancreatic tumor cells (Beil et al., 2003; Rolli et al., 2010) .
Keratin reorganization is achieved through phosphorylation of specifi c serine residues in keratin by MAP kinases, such as ERK, p38, and c-jun N-terminal kinase (JNK) (Ku et al., 2002; Park et al., 2011; Busch et al., 2012) . Several compounds such as sphingosylphosphorylcholine (SPC) and leukotriene B 4 induces keratin 8 (K8) phosphorylation and reorganization in PANC-1 cells (Beil et al., 2003; Park et al., 2011) . We also showed that BLT2 and transglutaminase-2 (Tgase-2) are involved in K8 phosphorylation and reorganization (Park et al., 2011; Park et al., 2012) .
Tgase-2 is a multifunctional protein. In addition to catalyzing Ca 2+ -dependent transamidation reactions, it can bind
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Biomol Ther 21(5), 338-342 (2013) www.biomolther.org and hydrolyze GTP/GDP (Mhaouty-Kodja, 2004) . The selective expression of Tgase-2 in chemoresistant and metastatic cancer cells, such as pancreatic, lung and ovarian tumors makes it a promising therapeutic target (Verma et al., 2006; Chhabra et al., 2009; Park et al., 2013b) . However, studies on Tgase-2 inhibitors modulating metastasis of cancers were not enough. We screened inhibitory effects of some compounds on Tgase-2. Ethacrynic acid (ECA) is a diuretic that inhibits cellular ion fl ux that leads to an increase in intracellular Na concentrations (Fig. 1A) (Vivas and Chiaraviglio, 1989; Li and El-Mallakh, 2004) . ECA is used rarely as a diuretic because other potent agents have been introduced. Nevertheless, ECA still has a place in the modern practice of medicine (Wall et al., 2003; Han et al., 2005) . ECA showed new pharmacological activities independent of diuretic activity. For example, ECA suppressed the all-retinoic acid-induced monocyte chemoattractant protein-1 production and is known to reduce the retinoid-induced ear edema in mice (Kim et al., 2010) .
In this study, we found that ECA inhibited Tgase-2 and confi rmed the involvement of Tgase-2 in SPC-induced K8 phosphorylation and reorganization. Our fi nding suggested the possibility that ECA might be used as antimetastatic drugs. 
MATERIALS AND METHODS

Material
Cell culture
The human pancreatic carcinoma cell line, PANC-1 (ATCC CRL 1469),was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). The cells were cultured in Dulbecco's modifi ed Eagle's medium (DMEM) supplemented with L-glutamine (2 mM), penicillin-streptomycin (10,000 IU/ml and 10,000 μg/ml, respectively), and sodium pyruvate (1 mM). The PANC-1 cells were maintained in medium containing 10% (v/v) fetal calf serum(FCS). The cells were incubated at 37 o C in a humidifi ed atmosphere containing 10% CO2. The cells were washed twice in serum-free DMEM and incubated in serum-free DMEM 18 hours before the respective experiments.
In vitro Tgase-2 inhibition assay
The inhibitory effect of each compound was determined by measuring the incorporation of [1,4-14C] putrescine into succinylated casein (Park et al., 2013a) . Following 10 min of preincubation of 2.5 milliunits (mU) of Tgase-2 from the guinea pig liver with each concentration of chemicals in 0.1 ml of reaction buffer solution without 10 mM CaCl 2 , we added 0.4 ml of substrate solution containing 5 mg of succinylated casein and 100 nCi of [1,4-14C] putrescine. After further incubation at 37 o C for 1 h, the reaction was terminated by the addition of 4 ml of cold (4 o C) 7.5% (w/v) TCA. TCA-insoluble precipitates were collected in GF/A glass fi ber fi lters (Millipore Co.), washed with cold 5% (w/v) TCA, dried and assessed for incorporation of radiolabel using a scintillation counter (Beckman Coulter Co.). The resultant data represent the means of three independent experiments.
Western blot
The PANC-1 cells were harvested and lysed in 50 mM TrisCl (pH7.5), 150 mM NaCl, 1% triton X-100, 1% sodium deoxycholate, 0.1% SDS, 2 mM EDTA, sterile solution and protease inhibitors (Gendepot, Barker, TX, USA) (Park et al., 2011) . The protein concentrations of the supernatants were determined using Coomassie Plus (Pierce Biotechnology Inc., Rockford, IL, USA), as recommended by the manufacturer. The protein lysates were loaded onto a precast 4% to 12% polyacrylamide gradient gel (Invitrogen, Carlsbad, CA, USA). The proteins were separated by SDS-PAGE and transferred to a polyvinylidene difl uoride membrane (Pall, Pensacola, FL, USA). The membranes were blocked in 5% non fat milk and probed with the appropriate primary antibodies such as anti-Tgase-2, keratin-8, and JNK. After incubation with the primary antibody, the membranes were washed with TBS+0.1% Tween 20 and incubated with the appropriate peroxidase-conjugated secondary antibodies followed by development with a chemiluminescence substrate (Pierce Biotechnology Inc., Rockford, IL, USA) and exposure to X-ray fi lm (Kodak, Rochester, NY, USA).
Confocal microscopy
PANC-1 cells were grown on coverslips and fi xed 24 hours later with fresh 4% paraformaldehyde, pH 7.0, for 10 min at room temperature. Fixed cells were permeabilized with a 10 min wash in 0.1% Triton X-100 at room temperature followed by several washes in PBS with 3% bovine serum albumin (PBS/BSA). The phosphospecifi c antibody detecting K8 Ser431 (Abcam, Cambridge, MA, USA) primary antibody was incubated with coverslips overnight at 4 o C (Park et al., 2011) . Excess antibody was removed with four washes in PBS/BSA. Species-specifi c second antibodies conjugated to goat antirabbit IgG antibody (Alexa Fluor 488, 1:500 Molecular Probes) or goat anti-mouse IgG antibodies (Alexa Fluor 594, 1:500, Molecular Probes) were then reacted with the coverslips for 1 hour at room temperature followed with four washes in PBS/ BSA. The fi nal samples were mounted onto slides and visualized using a Zeiss Axiophot confocal microscope.
Migration
Migration of PANC-1 cells through 8-μm size-limited pores was assessed in response to SPC according to Park's report (Park et al., 2011) . PANC-1 cells (5×10 4 cells per well) were treated with the indicated concentrations of SPC for 1 hour. PANC-1 cells plated in the upper chamber were allowed to migrate for 5 hours to establish the temporal kinetics of migration. The transwell membranes were then fi xed and stained with Diff-Quik ® staining kit (Kobe, Japan). Membranes were removed from transwells, and cells on the under surface of the millipore membrane were counted under a light microscope (average of 5 semi-random non-overlapping fi elds at 200× magnifi cation). All treatments were performed in triplicate wells.
Invasion assay using transwell plates
Cell invasion was studied using matrigel-coated (0.5 lg/ml) transwell inserts, as described previously (Park et al., 2013a) . Trypsinised cells were suspended in serum-free medium, and 2×10 5 cells were added to the upper chamber of the transwell inserts. Medium with 10% serum was added to the lower chamber. After a 16 h incubation with PANC-1 cells, the nonmigrated cells on the upper surface of the membrane were removed, and the cells on the lower surface were stained using the Hema 3 staining system (Fisher Scientifi c, Houston, TX, USA), photographed (200× magnifi cation) and counted in 10 randomly selected fi elds. All experiments were repeated at least three times with two replicates each.
Statistical analysis
The data are expressed as the mean ± S.E.M. of at least three in-dependent experiments performed in triplicate. A p value <0.05 was considered signifi cant.
RESULTS
ECA inhibits transglutaminase-2
We have shown that Tgase-2 is involved in SPC-induced K8 phosphorylation and reorganization by JNK activation leading to migration of metastatic pancreatic cancer cells (Park et al., 2011) . Therefore, Tgase-2 inhibitor may be effective for metastasis treatment. To obtain a Tgase-2 inhibitor, we fi rstly screened a single compound library comprised of used drugs and natural extracts. We found that ECA has a concentrationdependent Tgase-2 inhibitory effect (Fig. 1B) .
ECA suppressed the SPC-induced K8 phosphorylation and reorganization in PANC-1 cells
In previous report, cystamine (CTM), a well-known Tgase inhibitor, suppressed the SPC-induced K8 phosphorylation and reorganization (Park et al., 2011) . So we examined whether ECA, a newly found Tgase-2 inhibitor, could suppress the SPC-induced K8 phosphorylation and reorganization. SPC induced phosphorylation of serine 431 of K8 and ECA concentration dependently inhibited the SPC-induced K8 phosphorylation ( Fig. 2A) . SPC also induced ring like perinuclear reorganization of K8 in PANC-1 cells and Tgase-2 is involved in this event. ECA inhibited the SPC-induced perinuclear reorganization of K8 (Fig. 2B) .
ECA suppressed the SPC-induced migration and invasion of PANC-1 cells
The expected fi nal outcome of SPC-induced reorganization of the keratin network in PANC-1 cells is increased migratory properties (Beil et al., 2003) . Therefore, in previous report, we demonstrated that Tgase-2 is involved in the SPC-induced migration of PANC-1 cells by CTM and gene silencing (Park et al., 2011) . SPC treatment induced the increased migration and invasion of PANC-1 cells (Fig. 3) . ECA concentration-dependently inhibited the SPC-induced migration and invasion of PANC-1 cells (Fig. 3) . No cytotoxic effects of ECA were observed in our experimental setting of migration and invasion.
ECA suppressed the SPC-induced JNK activation and expression
Tgase-2 is involved in SPC-induced K8 phosphorylation via JNK activation (Park et al., 2011) . So, we examined whether ECA suppressed the Tgase-2-dependent JNK activation. SPC treatment increased the phosphorylation of JNK and ECA treatment suppressed the phosphorylation and expression of JNK (Fig. 4A) . www.biomolther.org
DISCUSSION
Metastatic cancer cells are reported to have unique mechanical characteristics, such as soft stiffness and elasticity (Cross et al., 2007) . Keratins are one of the main intermediate fi laments that control the mechanical characteristics of cells (Bordeleau et al., 2008) . This study focused on ECA, Tgase-2 inhibitor modulating the SPC-induced keratin phosphorylation and reorganization in PANC-1 cells that controls the viscoelasticity and migratory properties of cancer cells.
MAP kinase is involved in keratin reorganization through the phosphorylation of keratin (Ku et al., 2002; Park et al., 2011; Busch et al., 2012) , but there are few studies on the other proteins affecting keratin reorganization, except plectin (Cheng et al., 2008) . Recently, we reported that Tgase-2 is involved in SPC-induced keratin reorganization via JNK activation (Park et al, 2011) . Tgase-2 mediates the metastasis and chemoresistance of several cancer cells and is a new and interesting target (Kim, 2011) . However, effective Tgase-2 inhibitors are not yet available to clinical application although several approaches revealed promising Tgase-2 inhibitors Lee et al., 2013; Park et al., 2013a) . So, we examined inhibitory effects of some drugs on Tgase-2 since drug can be easily applicable to cancer treatment. We found that ECA concentration-dependently inhibited the Tgase-2 (Fig. 1B) . The inhibitory mechanism of ECA against Tgase-2 is not clear but the molecular structure of ECA contains an exo-methylene group conjugated to a carbonyl group (Fig. 1A) . This electrophilic "eneone" moiety can alkylate thiol groups in proteins or glutathione via a Michael-type addition reaction (Han et al., 2005) . Interestingly, one of key residues of Tgase-2 is cystein residue at 277 th amino acid (Lee et al., 1993) . Thus, ECA might modify critical thiol residues in 277 th Tgase-2. The results showed that ECA suppressed the phosphorylation of K8 and perinuclear keratin reorganization (Fig. 2) . These observations confi rmed that Tgase-2 is involved in SPC-induced K8 phosphorylation and perinuclear reorganization of K8 (Park et al., 2011) .
SPC-induced keratin phosphorylation and reorganization led to increased migration of PANC-1 cells and Tgase-2 inhibition by ECA suppressed the SPC-induced migration and invasion (Fig. 3) . ECA is known to have diverse effects such as glutathione-S-transferase inhibition and thiol-adduct formation. So these diverse effects also might be involved in inhibition of migration and invasion. However, to our knowledge, we could not fi nd reports about suppressing the migration of cancer cells via GST inhibition. However, thiol-adduct formation of ECA might contribute to inhibition of Tgase-2 since Tgase-2 has cystein residue at 277th in active site. In previous paper, we showed that SPC induced migration of PANC-1 cells via Tgase-2 expression (Park et al., 2011) . Therefore, ECA might suppress the SPC-induced migration by inhibition of Tgase-2. Tgase-2 is involved in SPC-induced JNK activation and ECA, Tgase-2 inhibitor, suppressed the JNK activation in PANC-1 cells (Fig. 4A) . Especially, ECA also suppressed the JNK expression (Fig. 4A) . These results suggested that ECA inhibited JNK expression via Tgase-2 inhibition.
Our fi ndings confi rmed the role of ECA as a Tgase-2 inhibitor in the suppression of SPC-induced K8 phosphorylation and reorganization of PANC-1 cells via JNK (Fig. 4B ). Therefore, ECA might be helpful in modulating the Tgase-2 involved metastasis of cancer cells such as pancreatic cancers, and lung cancers.
